Apogee Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for Apogee Therapeutics stock have an average target of 102.4, with a low estimate of 82 and a high estimate of 137. The average target predicts an increase of 43.18% from the current stock price of 71.52.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$82	$102.4	$103	$137
Change	+14.65%	+43.18%	+44.02%	+91.55%

Analyst Ratings

The average analyst rating for Apogee Therapeutics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	5	6	6	6	6	6
Buy	3	3	3	2	2	3
Hold	0	0	0	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	9	9	10	10	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brian Abrahams RBC Capital	RBC Capital	Hold Maintains $83 → $82	Hold	Maintains	$83 → $82	+14.65%	Mar 3, 2026
David Nierengarten Wedbush	Wedbush	Buy Maintains $90 → $95	Buy	Maintains	$90 → $95	+32.83%	Mar 3, 2026
Brian Abrahams RBC Capital	RBC Capital	Buy → Hold Downgrades $70 → $83	Buy → Hold	Downgrades	$70 → $83	+16.05%	Jan 22, 2026
Andy Chen Wolfe Research	Wolfe Research	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Jan 7, 2026
Julian Harrison BTIG	BTIG	Strong Buy Maintains $128 → $137	Strong Buy	Maintains	$128 → $137	+91.55%	Jan 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-5.05

from -4.22

EPS Next Year

-6.05

from -5.05

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	-	-	-	-	-	29.07M
Revenue Growth	-	-	-	-	-	-	-
EPS	-17.63	-3.36	-3.30	-4.22	-5.05	-6.05	-5.65
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	18	14	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-4.08	-4.19
Avg	-5.05	-6.05
Low	-7.27	-12.81

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.